CMO Letter 

As a Harvard-trained orthopedic spine surgeon with extensive experience in medical device development and clinical trials for multiple disc replacements, I’ve dedicated my career to advancing spine care. This commitment led me to invest my own resources and join KIC Ventures, recognizing the transformative potential of LESS Exposure Spine Surgery (LESS™).

​

 

Having successfully run my own surgery center, I’ve witnessed how LESS technologies elevate patient outcomes by reducing recovery time and enhancing overall care. As one of the clinical investigators for the first and only lateral disc replacement trial by NuVasive, I’m now eager to leverage this expertise to lead the way with AxioMed’s lateral disc replacement.

​

 

This is our opportunity to pioneer a new future in spine surgery. Together, we will create a legacy of innovative, patient-centered solutions that will transform care for generations.

​

Sincerely,

 

Erik C. Spayde MD

Harvard-Trained | Board-certified Orthopedic Spine Surgeon

Chief Medical Officer

KIC Ventures